MiMedx GroupMDXG -0.51%57 Days Inventory is 135.47 as of Mar. 2026, which is 14% above its 10-year median of 118.56. GuruFocus rates MDXG with a GF Score™ of 57/100 and a GF Value™ of $6.96 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, MiMedx Group ranks better than 64.58% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). MiMedx Group's Average Total Inventories for the
three
months ended in Mar. 2026 was $25.8 Mil. MiMedx Group's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $17.4 Mil.
Hence, MiMedx Group's Days Inventory for the
three
months ended in Mar. 2026 was 135.47.
The historical rank and industry rank for MiMedx Group's Days Inventory or its related term are showing as below:
MDXG'
s Days Inventory Range Over the Past 10 Years
Min: 90.32 Med: 118.56 Max: 149.09
Current: 125.61
During the past 13 years, MiMedx Group's highest Days Inventory was 149.09. The lowest was 90.32. And the median was 118.56.
MDXG's Days Inventory is ranked better than 64.58% of 638
companies
in the Biotechnology industry
Industry Median: 183.875
vs MDXG: 125.61
MiMedx Group's Days Inventory
increased
from Mar. 2025 (131.92) to Mar. 2026 (135.47).
It might indicate that MiMedx Group's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
MiMedx Group's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MiMedx Group's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.44.
MiMedx Group (NAS:MDXG) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
MiMedx Group's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MiMedx Group's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
MiMedx Group Days Inventory Related Terms
MiMedx Group Days Inventory Historical Data
* Premium members only.
The historical data trend for MiMedx Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDXG vs MNPR, FTH, BBOT: Days Inventory Comparison
For the Biotechnology subindustry, MiMedx Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MiMedx Group Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MiMedx Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where MiMedx Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MiMedx Group (MDXG) has a Days Inventory of 135.47 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MiMedx Group and its competitors. This is 14% above median its historical median of 118.56. Over the past decade, MiMedx Group's Days Inventory has ranged from 90.32 to 149.09. According to the industry distribution chart, MiMedx Group ranks #226 out of 638 companies in the Biotechnology industry, placing it in the top 35.4%.
Is MiMedx Group's Days Inventory too high?
MiMedx Group's current Days Inventory of 135.47 is 14% above median its 10-year median of 118.56. Over the past 10 years, this metric has ranged from a low of 90.32 to a high of 149.09. The Biotechnology industry median Days Inventory is 183.88. MiMedx Group's value of 135.47 is 26.3% below this industry median. Based on the distribution chart, MiMedx Group ranks #226 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, MiMedx Group has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MiMedx Group's Days Inventory compare to MNPR and FTH?
According to the Biotechnology industry distribution chart, MiMedx Group ranks #226 out of 638 companies for Days Inventory. This puts MiMedx Group in the upper half of its industry. The industry median Days Inventory is 183.88. MiMedx Group's value of 135.47 is 26.3% below this benchmark. Historically, MiMedx Group's own Days Inventory has ranged from 90.32 to 149.09 over the past decade. While the company's 10-year median is 118.56 vs. the industry median of 183.88, MiMedx Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MiMedx Group's current Days Inventory of 135.47 is 26.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MiMedx Group and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MiMedx Group's current Days Inventory is 135.47, which is 14% above median its own 10-year median of 118.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MiMedx Group stock overvalued right now?
Based on GuruFocus' analysis, MiMedx Group (MDXG) is currently considered Significantly Undervalued. The stock's GF Value™ is $6.96, compared to a current price of $3.91 — trading 43.8% below its estimated fair value. The current Days Inventory is 135.47, which is 14% above median its 10-year median of 118.56 and 26.3% below the Biotechnology industry median of 183.88. MiMedx Group's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MiMedx Group (MDXG), the current Days Inventory is 135.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MiMedx Group (MDXG) Overvalued in 2026?
Based on GuruFocus' analysis, MiMedx Group stock appears to be undervalued.
The current stock price of $3.91 is trading 43.8% below its estimated GF Value™ of $6.96.
GuruFocus considers MiMedx Group to be Significantly Undervalued.
Key valuation signals for MDXG:
Days Inventory: 135.47 (14% above median its 10-year median of 118.56)
GF Value™: $6.96 vs. price of $3.91 (43.8% below fair value)
Industry Position: 26.3% below the Biotechnology median (#226 of 638)
No single metric tells the full story. See the MDXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
57GF Score
Get the complete analysis for MDXG
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDXG has been successfully added to your 
